Literature DB >> 10848491

Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?

S L Sherman.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10848491      PMCID： PMC1287068          DOI： 10.1086/302985

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  7 in total

1.  Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile X.

Authors:  A M Vianna-Morgante; S S Costa
Journal:  Am J Hum Genet       Date:  2000-07       Impact factor: 11.025

2.  No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers.

Authors:  A Murray; S Ennis; N Morton
Journal:  Am J Hum Genet       Date:  2000-07       Impact factor: 11.025

3.  Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features.

Authors:  A Cronister; R Schreiner; M Wittenberger; K Amiri; K Harris; R J Hagerman
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

4.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

Authors:  F Tassone; R J Hagerman; A K Taylor; L W Gane; T E Godfrey; P J Hagerman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

5.  Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data.

Authors:  D J Allingham-Hawkins; R Babul-Hirji; D Chitayat; J J Holden; K T Yang; C Lee; R Hudson; H Gorwill; S L Nolin; A Glicksman; E C Jenkins; W T Brown; P N Howard-Peebles; C Becchi; E Cummings; L Fallon; S Seitz; S H Black; A M Vianna-Morgante; S S Costa; P A Otto; R C Mingroni-Netto; A Murray; J Webb; F Vieri
Journal:  Am J Med Genet       Date:  1999-04-02

6.  Obstetrical and gynecological complications in fragile X carriers: a multicenter study.

Authors:  C E Schwartz; J Dean; P N Howard-Peebles; M Bugge; M Mikkelsen; N Tommerup; C Hull; R Hagerman; J J Holden; R E Stevenson
Journal:  Am J Med Genet       Date:  1994-07-15

7.  Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.

Authors:  R D Hundscheid; E A Sistermans; C M Thomas; D D Braat; H Straatman; L A Kiemeney; B A Oostra; A P Smits
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025
  7 in total
  22 in total

1.  Newborn screening and cascade testing for FMR1 mutations.

Authors:  Page L Sorensen; Louise W Gane; Mark Yarborough; Randi J Hagerman; Flora Tassone
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

2.  Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.

Authors:  Annie Killoran; Kevin M Biglan; Joseph Jankovic; Shirley Eberly; Elise Kayson; David Oakes; Anne B Young; Ira Shoulson
Journal:  Neurology       Date:  2013-04-26       Impact factor: 9.910

Review 3.  Reproductive tract function and dysfunction in women.

Authors:  Angshumoy Roy; Martin M Matzuk
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

4.  An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene.

Authors:  Alessandro Saluto; Alessandro Brussino; Flora Tassone; Carlo Arduino; Claudia Cagnoli; Patrizia Pappi; Paul Hagerman; Nicola Migone; Alfredo Brusco
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

Review 5.  FXTAS: a progressive neurologic syndrome associated with Fragile X premutation.

Authors:  Rob Willemsen; Edwin Mientjes; Ben A Oostra
Journal:  Curr Neurol Neurosci Rep       Date:  2005-09       Impact factor: 5.081

6.  Health knowledge of women with a fragile X premutation: Improving understanding with targeted educational material.

Authors:  Liana Smolich; Krista Charen; Stephanie L Sherman
Journal:  J Genet Couns       Date:  2020-01-30       Impact factor: 2.537

Review 7.  Pharmacotherapy for Fragile X Syndrome: Progress to Date.

Authors:  Matthew H Davenport; Tori L Schaefer; Katherine J Friedmann; Sarah E Fitzpatrick; Craig A Erickson
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

Review 8.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

9.  Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.

Authors:  Cuiling Lu; Li Lin; Huiping Tan; Hao Wu; Stephanie L Sherman; Fei Gao; Peng Jin; Dahua Chen
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

Review 10.  The FMR1 gene and fragile X-associated tremor/ataxia syndrome.

Authors:  J R Brouwer; R Willemsen; B A Oostra
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.